Literature DB >> 10575322

The antihypertensive effect of the berberine derivative 6-protoberberine in spontaneously hypertensive rats.

J C Liu1, P Chan, Y J Chen, B Tomlinson, S H Hong, J T Cheng.   

Abstract

Berberine is a natural isoquinoline alkaloid found in plants of the Ranunculaceae and Berberidaceae families. Extracts from berberine-containing plants have been used as traditional Chinese folk remedies for centuries. The antihypertensive effects of the berberine derivative 6-protoberberine (PTB-6) were studied in spontaneously hypertensive rats (SHRs). In conscious SHRs, PTB-6 lowered the systolic blood pressure in a dose-dependent manner (6-PTB: 5 mg/kg, -31.1 +/- 1.6 mm Hg; 10 mg/kg, -42.4 +/- 3.1 mm Hg). Cardiac output using the thermodilution method was reduced in PTB-6-treated anesthetized SHRs with a tendency to decrease in heart rate. Injection of PTB-6 into the intracerebral ventricles of SHRs lowered the systolic arterial blood pressure and heart rate. The berberine derivative PTB-6 is an effective antihypertensive agent. The mechanism of the antihypertensive effect of PTB-6 is probably through a central sympatholytic effect. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10575322     DOI: 10.1159/000028331

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  8 in total

Review 1.  Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases.

Authors:  Mei-qing Liu; Zhe Chen; Lin-xi Chen
Journal:  Acta Pharmacol Sin       Date:  2016-02-01       Impact factor: 6.150

2.  Berberine attenuates mitochondrial dysfunction by inducing autophagic flux in myocardial hypoxia/reoxygenation injury.

Authors:  Na Zhu; Xueming Cao; Peiyuan Hao; Yuwei Zhang; Yan Chen; Jing Zhang; Jiang Li; Chuanyu Gao; Li Li
Journal:  Cell Stress Chaperones       Date:  2020-02-22       Impact factor: 3.667

Review 3.  Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics.

Authors:  Xiaojun Feng; Antoni Sureda; Samineh Jafari; Zahra Memariani; Devesh Tewari; Giuseppe Annunziata; Luigi Barrea; Sherif T S Hassan; Karel Šmejkal; Milan Malaník; Alice Sychrová; Davide Barreca; Lovro Ziberna; Mohamad Fawzi Mahomoodally; Gokhan Zengin; Suowen Xu; Seyed Mohammad Nabavi; Ai-Zong Shen
Journal:  Theranostics       Date:  2019-03-16       Impact factor: 11.556

4.  Binding of the 9-O-N-aryl/arylalkyl amino carbonyl methyl substituted berberine analogs to tRNA(phe.).

Authors:  Anirban Basu; Parasuraman Jaisankar; Gopinatha Suresh Kumar
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

5.  Melatonin inhibits AP-2β/hTERT, NF-κB/COX-2 and Akt/ERK and activates caspase/Cyto C signaling to enhance the antitumor activity of berberine in lung cancer cells.

Authors:  Jian-Jun Lu; Lingyi Fu; Zhipeng Tang; Changlin Zhang; Lijun Qin; Jingshu Wang; Zhenlong Yu; Dingbo Shi; Xiangsheng Xiao; Fangyun Xie; Wenlin Huang; Wuguo Deng
Journal:  Oncotarget       Date:  2016-01-19

Review 6.  Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art.

Authors:  Beniamino Pagliaro; Caterina Santolamazza; Francesca Simonelli; Speranza Rubattu
Journal:  Biomed Res Int       Date:  2015-10-04       Impact factor: 3.411

7.  Berberine inhibits cardiac remodeling of heart failure after myocardial infarction by reducing myocardial cell apoptosis in rats.

Authors:  Ying Liao; Kaihong Chen; Xingmo Dong; Weiguo Li; Ganyang Li; Guoyong Huang; Wei Song; Liling Chen; Yong Fang
Journal:  Exp Ther Med       Date:  2018-07-11       Impact factor: 2.447

Review 8.  Promising Antioxidative Effect of Berberine in Cardiovascular Diseases.

Authors:  Na An; Guoxia Zhang; Yingjian Li; Chao Yuan; Fan Yang; Lijing Zhang; Yonghong Gao; Yanwei Xing
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.